InnovoCommerce
Clinical AI Orchestration

Lead with Precision. Scale with Confidence.

End-to-end AI transformation from clinical development to operations — one connected system from protocol to live monitoring.

The Problem

"The FDA found it. Why didn't we?"

Why it keeps happening

Trials are built as a sequence of handoffs, not a system — and intelligence is lost at every one. Now the bar has moved: oversight must be risk-based and technology-enabled. The old way no longer clears it.

The regulatory bar has moved

Two frameworks now define what good oversight looks like — and both expect technology-enabled, auditable processes.

ICH E6(R3) — GCP · FDA-adopted · Sep 2025

Risk-based, quality-by-design oversight

The first GCP overhaul in three decades — explicitly embracing modern technology, data governance, and risk-based monitoring across the trial.

FDA AI Guidance · Draft · Jan 2025

AI must be credible & risk-assessed

The FDA's first framework for AI in drug development sets a risk-based bar for the credibility of any model that informs a regulatory decision.

The breaks are structural, not effort

30–40% of trial-timeline delays accumulate before a single patient is enrolled.

Days to detect

Breaches sit unnoticed until the next manual check.

Siloed systems

EDC, CTMS, eTMF and training data don't talk to each other.

No closed loop

CAPAs open, but nothing verifies the fix actually worked.

One agent layer across the whole trial

The Unified Clinical AI Intelligence Platform — a single layer of AI agents reasoning across every process, every source, and every system, so intelligence never gets lost in the handoff.

  • Clinical processes: R&D → Protocol → Study Startup → Execution & Monitoring → Submission
  • Clinical systems: your internal AI platform, EDC, eTMF, CTMS — connected, not replaced
  • Knowledge: trial documents, SOPs & regulatory standards, templates, operational signals, plus external sources — competitor trials, real-world data, scientific literature
One agent layer across the whole trial

Two products. One loop.

For clinical development & operations

Innovo Copilot

Research → Author → Monitor. Three modules, one loop — evidence-grounded study design, governed authoring, and risk-based live oversight that closes breach to verified CAPA.

Explore Innovo Copilot
For site engagement & operations

StudyCloud

The enterprise investigator platform that keeps 60,000+ sites engaged, trained, and inspection-ready — training, startup, document exchange, and safety distribution in one place.

Explore StudyCloud
Proof

The loop, closed — and the outcomes we measure

~80%
Faster breach-to-CAPA
2–3
Fewer amendments per study
40–50%
Fewer protocol deviations
30–50%
Expanded CRA capacity
800+
Global trials
60,000+
Global sites
300,000+
Global users
60+
Countries

Trusted by top sponsors & CROs

“InnovoCommerce has been a reliable partner in supporting our central clinical operations — their platform brings the visibility and consistency global trials demand.”
Dr. Mark Hopley
Head of Central Clinical Operations, Boehringer Ingelheim
“The platform streamlines how our teams and sites work together across studies — engagement and oversight in one place.”
Dr. Jeannett Dimsits
Vice President, Novo Nordisk
Why InnovoCommerce

Founded by the team that introduced Argus Safety in 1998

For over 20 years, InnovoCommerce has supported global clinical operations at enterprise scale — trusted by top sponsors and CROs, with deep integration into the systems trials already run on, and a track record of significant customer savings.

“If it doesn't change trial timelines, it's not a solution.”

Heritage
Argus Safety, 1998
Experience
20+ years in clinical ops
Integration
EDC · CTMS · eTMF

One protocol. Every plan. Live intelligence. End to end.

Proof of Outcome — not just Proof of Concept. We'll baseline your current metrics and prove the impact on a real study workflow.

Request a Demo